Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Completed

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

NCT00618618

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Toorak, Victoria, Australia
  • Investigational Site Sydney, Australia
  • Investigational Site Niagara Falls, Ontario, Canada
  • Investigational Site Oakville, Ontario, Canada
View Trial Details
Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions
Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 23 locations
View Trial Details
Completed

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

NCT01032889

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site San Francisco, California, United States
View Trial Details
Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01542034

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Irvine, California, United States
View all 36 locations
View Trial Details
Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01546142

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Little Rock, Arkansas, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Los Angeles, California, United States
  • Investigational Site Sacramento, California, United States
View all 35 locations
View Trial Details
Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

NCT01294644

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Geel, Belgium
  • Investigational Site Genk, Belgium
  • Investigational Site Besançon, France
  • Investigational Site Nice, France
View all 29 locations
View Trial Details

Related conditions